查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128380

非侵入性脊髓電刺激市場規模、佔有率、成長率、全球產業分析、區域趨勢及2026-2034年預測。

Non invasive Spinal Cord Stimulation Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

非侵入性脊髓電刺激市場的成長要素

全球非侵入性脊髓刺激市場預計在2025年達到420萬美元，並從2026年的790萬美元成長至2034年的6,650萬美元，預測期內複合年成長率高達30.4%。北美市場佔據全球主導地位，預計到2025年將佔據95.23%的市場佔有率，這主要得益於法規核准的快速推進、先進神經復健技術的廣泛應用以及完善的醫療保健基礎設施。

非侵入性脊髓刺激（SCS）是一種先進的神經調控療法，它透過放置在脊髓上方皮膚上的電極傳遞電刺激。與植入式系統不同，這些設備無需手術，即可幫助脊髓損傷和神經系統疾病患者進行復健。脊髓損傷發生率的上升、人們對非侵入性療法的偏好日益成長以及對復健技術投資的不斷增加，正在加速全球市場的成長。根據世界衛生組織（WHO）統計，全球約有1500萬人患有脊髓損傷，這催生了對創新復健解決方案的巨大需求。

市場趨勢

影響非侵入性脊髓刺激（tSCS）市場的關鍵趨勢之一是從植入式神經調控系統轉向體外刺激技術。經皮脊髓刺激（tSCS）設備因其無需侵入性手術即可有效促進神經功能恢復，正日益被復健醫院、專科診所和家庭治療機構所採用。

臨床證據持續提振市場信心。 2024年發表於《自然醫學》雜誌的一項研究表明，將頸椎外部脊髓刺激與復健治療相結合，可顯著改善慢性四肢癱瘓患者的手部和手臂功能。 Up-LIFT臨床試驗也取得了類似的正面成果，加速了這些創新療法的商業化和廣泛應用。

市場促進因素

脊髓損傷造成的日益沉重的負擔仍然是市場成長的主要驅動力。隨著對改善活動能力、上肢功能、神經功能恢復和生活品質的療法的需求不斷成長，醫療保健專業人員正在推動非侵入性脊髓刺激設備的應用。

根據克里斯多福和達納·里夫基金會的數據，預計到2026年，美國脊髓損傷的年發生率將達到每百萬人約54例。此外，復健基礎設施的擴建、產品核可的增加以及主要製造商對研發的持續投入，都在推動市場的快速成長。

市場限制因素

儘管脊髓刺激療法具有巨大的成長潛力，但有限的保險報銷政策仍限制其市場滲透。許多醫療系統仍然缺乏針對非侵入性脊髓刺激療法的標準化保險報銷流程，這加重了醫院、復健中心和患者的經濟負擔。

總治療費用包括刺激器、復健療程、臨床醫生培訓、後續觀察和治療管理，因此在一些國家，成本效益是一個主要問題。這些保險報銷限制持續減緩該療法的普及速度，尤其是在新興醫療市場。

市場機遇

開發中國家醫療基礎設施的快速擴張為行業相關人員帶來了巨大的機會。印度、巴西和一些新興經濟體正在對醫院、復健中心和神經科治療設施進行大量投資。

人們對非侵入性復健技術的認知不斷提高，加上醫療保健服務的改善以及對先進脊髓損傷治療的需求不斷成長，預計將在整個預測期內創造良好的成長機會。

市場區隔

按產品類型分類，由於市場對先進的非侵入式脊髓電刺激治療設備的需求不斷成長，刺激系統細分市場在2025年佔據主導地位。預計配件細分市場在預測期內將實現最快成長，複合年成長率將達到35.9%。

按技術分類，經皮脊髓電刺激（tSCS）預計到2025年將佔據97.9%的最大市場佔有率，這得益於其強大的臨床檢驗和不斷增加的法規核准。在預測期內，經脊髓磁刺激領域預計將實現最高成長。

按刺激部位分類，頸椎節段預計將成為市場成長的主要驅動力，到2025年將佔據85.9%的市場佔有率。這主要歸因於頸椎脊髓損傷的高發生率以及旨在恢復上肢功能的復健療法的日益普及。胸椎節段預計到2034年也將顯著成長。

按應用領域分類，預計2025年，脊髓損傷復健將佔最大佔有率，達到48.9%，這反映出臨床上越來越重視運動和神經功能的恢復。自主神經功能障礙的治療領域預計在整個預測期內將快速成長。

就終端用戶而言，醫院在2025年仍將是主要用戶群體，預計到2026年將佔據82.9%的市場佔有率，這主要得益於復健服務的擴展和醫院基礎設施的改善。專科診所預計也將顯著成長。

區域展望

預計北美將引領全球市場，2025年市場規模將達400萬美元。強勁的醫療費用支出、脊髓損傷盛行率的上升、FDA持續批准新產品以及先進神經刺激技術的快速商業化，將繼續鞏固該地區的主導地位。預計到2026年，美國市場規模將達到約720萬美元，佔全球銷售額的近90.8%。

在神經復健計畫增加和非侵入性治療技術普及的支持下，預計到 2026 年，歐洲的神經復健市場規模將達到約 60 萬美元，成長率在各地區中排名第二。

亞太地區仍是一個新興市場，預計從2027年起，在中國、印度和日本醫療基礎設施擴張的推動下，商業化進程將加速。拉丁美洲、中東和非洲地區預計也將實現溫和成長，這得益於復健設施的建設和醫療保健領域投資的增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家和地區主要疾病的流行情況
  • 管道分析，主要公司
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：全球非侵入性脊髓刺激市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按產品類型分類
    • 刺激系統
    • 配件
  • 市場分析、洞察與預測：按技術分類
    • 經皮脊髓電刺激（tSCS）
    • 經脊髓磁刺激
    • 其他
  • 市場分析、洞察與預測：按刺激場地分類
    • 頸椎
    • 胸椎
    • 腰薦椎
  • 市場分析、洞察與預測：按應用領域分類
    • 脊髓損傷康復
    • 中風和神經運動復健
    • 自主神經系統功能障礙的管理
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 專科診所
    • 居家照護環境
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美非侵入性脊髓刺激市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：2021-2034年歐洲非侵入性脊髓刺激療法市場分析、洞察與預測

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區非侵入性脊髓刺激療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲非侵入性脊髓刺激市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：2021-2034年中東和非洲非侵入性脊髓刺激療法市場分析、洞察與預測

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • ONWARD Medical
    • ANEUVO
    • SpineX Inc.
    • COSIMA
    • University of Washington
    • Kessler Foundation
    • University of Louisville
    • University of Miami
Product Code: FBI117698

Growth Factors of non-invasive spinal cord stimulation Market

The global non-invasive spinal cord stimulation market was valued at USD 4.2 million in 2025 and is projected to grow from USD 7.9 million in 2026 to USD 66.5 million by 2034, registering an impressive CAGR of 30.4% during the forecast period. North America dominated the global market with a 95.23% market share in 2025, driven by rapid regulatory approvals, increasing adoption of advanced neurorehabilitation technologies, and strong healthcare infrastructure.

Non-invasive spinal cord stimulation (SCS) is an advanced neuromodulation therapy that delivers electrical stimulation through electrodes placed on the skin over the spinal cord. Unlike implantable systems, these devices eliminate the need for surgery while supporting rehabilitation for patients with spinal cord injuries and neurological disorders. Rising incidences of spinal cord injuries, increasing preference for non-invasive therapies, and growing investments in rehabilitation technologies are accelerating market expansion worldwide. According to the World Health Organization (WHO), nearly 15 million people worldwide are living with spinal cord injuries, creating significant demand for innovative rehabilitation solutions.

Market Trends

One of the major trends shaping the non-invasive spinal cord stimulation market is the shift from implantable neuromodulation systems toward external stimulation technologies. Transcutaneous spinal cord stimulation (tSCS) devices are increasingly being adopted in rehabilitation hospitals, specialty clinics, and home-based therapy settings because they offer effective neurological recovery without invasive surgery.

Clinical evidence continues to strengthen market confidence. A 2024 Nature Medicine study demonstrated that external cervical spinal cord stimulation combined with rehabilitation significantly improved hand and arm function among patients with chronic tetraplegia. Similar positive outcomes from the Up-LIFT clinical study have accelerated commercialization and adoption of these innovative therapies.

Market Drivers

The increasing burden of spinal cord injuries remains the primary driver of market growth. Growing demand for treatments that improve mobility, upper limb function, neurological recovery, and quality of life is encouraging healthcare providers to adopt non-invasive spinal cord stimulation devices.

According to the Christopher & Dana Reeve Foundation, the annual incidence of spinal cord injury in the U.S. reached approximately 54 cases per one million people in 2026. In addition, expanding rehabilitation infrastructure, increasing product approvals, and continuous investment in research and development by leading manufacturers are supporting rapid market expansion.

Market Restraints

Despite strong growth potential, limited reimbursement policies continue to restrict market adoption. Many healthcare systems have yet to establish standardized reimbursement pathways for non-invasive spinal cord stimulation therapies, increasing the financial burden on hospitals, rehabilitation centers, and patients.

The total treatment cost includes the stimulation device, rehabilitation sessions, clinician training, follow-up care, and therapy management, making affordability a major concern in several countries. These reimbursement limitations continue to slow adoption, particularly in emerging healthcare markets.

Market Opportunities

Rapid expansion of healthcare infrastructure across developing countries presents significant opportunities for industry participants. Countries such as India, Brazil, and several emerging economies are investing heavily in hospitals, rehabilitation centers, and neurological care facilities.

Increasing awareness of non-invasive rehabilitation technologies, combined with improving healthcare access and rising demand for advanced spinal cord injury treatments, is expected to create favorable growth opportunities throughout the forecast period.

Market Segmentation

Based on product type, the stimulation systems segment dominated the market in 2025 owing to increasing demand for advanced non-invasive spinal cord stimulation devices. The accessories segment is projected to register the fastest growth with a 35.9% CAGR during the forecast period.

By technology, transcutaneous electrical spinal cord stimulation (tSCS) accounted for the largest market share of 97.9% in 2025, supported by strong clinical validation and increasing regulatory approvals. The transspinal magnetic stimulation segment is anticipated to witness the highest growth during the forecast period.

Based on stimulation site, the cervical spine segment dominated with an 85.9% market share in 2025, driven by the high prevalence of cervical spinal cord injuries and increasing use of rehabilitation therapies for upper-limb functional recovery. The thoracic spine segment is expected to experience significant growth through 2034.

By application, spinal cord injury rehabilitation accounted for the largest share of 48.9% in 2025, reflecting the growing clinical focus on restoring movement and neurological function. The autonomic dysfunction management segment is expected to grow rapidly over the forecast period.

Based on end user, hospitals remained the leading segment in 2025 and are expected to account for 82.9% of the market in 2026, supported by expanding rehabilitation services and increasing hospital infrastructure. Specialty clinics are also projected to witness substantial growth.

Regional Outlook

North America dominated the global market with a valuation of USD 4.0 million in 2025. Strong healthcare expenditure, rising prevalence of spinal cord injuries, continuous FDA approvals, and rapid commercialization of advanced neurostimulation technologies continue to support regional leadership. The U.S. market is estimated to reach approximately USD 7.2 million in 2026, representing nearly 90.8% of global revenue.

Europe is expected to record the second-highest regional growth, reaching approximately USD 0.6 million in 2026, supported by increasing neurological rehabilitation programs and growing adoption of non-invasive treatment technologies.

Asia Pacific remains an emerging market with commercialization expected to accelerate after 2027 as healthcare infrastructure expands across China, India, and Japan. Latin America and the Middle East & Africa are also projected to witness gradual growth due to improving rehabilitation facilities and increasing healthcare investments.

Competitive Landscape

The market remains highly competitive with companies focusing on regulatory approvals, product innovation, clinical research, and commercialization strategies. Strong research collaborations and continuous product development are strengthening competitive positioning.

Major companies operating in the market include ONWARD Medical, ANEUVO, SpineX Inc., COSIMA, University of Washington, Kessler Foundation, University of Louisville, and University of Miami.

Key Industry Developments

Several important developments have accelerated market growth. In April 2026, ANEUVO received FDA approval for its ExaStim Stimulation System, strengthening its commercial presence. In November 2025, ONWARD Medical secured FDA approval for home use of its ARC-EX System in the U.S. SpineX Inc. also received regulatory approval in India for its xStep device during October 2025, expanding its international footprint. Earlier approvals, including FDA De Novo authorization and CE Mark certification for ONWARD Medical's ARC-EX System during 2024 and 2025, have significantly accelerated global commercialization.

Conclusion

The global non-invasive spinal cord stimulation market is expected to witness exceptional growth between 2025 and 2034, driven by increasing spinal cord injury prevalence, rapid technological advancements, favorable regulatory approvals, and expanding rehabilitation infrastructure. The growing preference for non-invasive neuromodulation therapies, coupled with continued investment in clinical research and innovative stimulation technologies, is expected to create substantial growth opportunities for manufacturers and healthcare providers worldwide throughout the forecast period.

Segmentation By Product Type, Technology, Stimulation Site, Application, End User, and Region

By Product Type * Stimulation Systems

  • Accessories

By Technology * Transcutaneous Electrical Spinal Cord Stimulation (tSCS)

  • Transspinal Magnetic Stimulation
  • Others

By Stimulation Site * Cervical Spine

  • Thoracic Spine
  • Lumbosacral Spine

By Application * Spinal Cord Injury Rehabilitation

  • Stroke & Neurological Motor Rehabilitation
  • Autonomic Dysfunction Management
  • Others

By End User * Hospitals

  • Specialty Clinics
  • Homecare Settings
  • Others

By Region * North America (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country)

    • U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
    • U.K. (By Product Type)
    • Germany (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Scandinavia (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
    • China (By Product Type)
    • Japan (By Product Type)
    • India (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
    • GCC (By Product Type)
    • South Africa (By Product Type)
    • Rest of the Middle East & Africa (By Product Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Region, 2025
  • 4.2. Pipeline Analysis, Key Players
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Stimulation Systems
    • 5.1.2. Accessories
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 5.2.2. Transspinal Magnetic Stimulation
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 5.3.1. Cervical Spine
    • 5.3.2. Thoracic Spine
    • 5.3.3. Lumbosacral Spine
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Spinal Cord Injury Rehabilitation
    • 5.4.2. Stroke & Neurological Motor Rehabilitation
    • 5.4.3. Autonomic Dysfunction Management
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Hospitals
    • 5.5.2. Specialty Clinics
    • 5.5.3. Homecare Settings
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Stimulation Systems
    • 6.1.2. Accessories
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 6.2.2. Transspinal Magnetic Stimulation
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 6.3.1. Cervical Spine
    • 6.3.2. Thoracic Spine
    • 6.3.3. Lumbosacral Spine
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Spinal Cord Injury Rehabilitation
    • 6.4.2. Stroke & Neurological Motor Rehabilitation
    • 6.4.3. Autonomic Dysfunction Management
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Hospitals
    • 6.5.2. Specialty Clinics
    • 6.5.3. Homecare Settings
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Product Type
    • 6.6.2. Canada
      • 6.6.2.1. By Product Type

7. Europe Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Stimulation Systems
    • 7.1.2. Accessories
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 7.2.2. Transspinal Magnetic Stimulation
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 7.3.1. Cervical Spine
    • 7.3.2. Thoracic Spine
    • 7.3.3. Lumbosacral Spine
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Spinal Cord Injury Rehabilitation
    • 7.4.2. Stroke & Neurological Motor Rehabilitation
    • 7.4.3. Autonomic Dysfunction Management
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Hospitals
    • 7.5.2. Specialty Clinics
    • 7.5.3. Homecare Settings
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Product Type
    • 7.6.2. Germany
      • 7.6.2.1. By Product Type
    • 7.6.3. France
      • 7.6.3.1. By Product Type
    • 7.6.4. Spain
      • 7.6.4.1. By Product Type
    • 7.6.5. Italy
      • 7.6.5.1. By Product Type
    • 7.6.6. Scandinavia
      • 7.6.6.1. By Product Type
    • 7.6.7. Rest of Europe
      • 7.6.7.1. By Product Type

8. Asia Pacific Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Stimulation Systems
    • 8.1.2. Accessories
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 8.2.2. Transspinal Magnetic Stimulation
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 8.3.1. Cervical Spine
    • 8.3.2. Thoracic Spine
    • 8.3.3. Lumbosacral Spine
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Spinal Cord Injury Rehabilitation
    • 8.4.2. Stroke & Neurological Motor Rehabilitation
    • 8.4.3. Autonomic Dysfunction Management
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Hospitals
    • 8.5.2. Specialty Clinics
    • 8.5.3. Homecare Settings
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Product Type
    • 8.6.2. Australia
      • 8.6.2.1. By Product Type
    • 8.6.3. China
      • 8.6.3.1. By Product Type
    • 8.6.4. India
      • 8.6.4.1. By Product Type
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Product Type
    • 8.6.6. Rest of Asia Pacific
      • 8.6.6.1. By Product Type

9. Latin America Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Stimulation Systems
    • 9.1.2. Accessories
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 9.2.2. Transspinal Magnetic Stimulation
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 9.3.1. Cervical Spine
    • 9.3.2. Thoracic Spine
    • 9.3.3. Lumbosacral Spine
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Spinal Cord Injury Rehabilitation
    • 9.4.2. Stroke & Neurological Motor Rehabilitation
    • 9.4.3. Autonomic Dysfunction Management
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Hospitals
    • 9.5.2. Specialty Clinics
    • 9.5.3. Homecare Settings
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Product Type
    • 9.6.2. Mexico
      • 9.6.2.1. By Product Type
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Product Type

10. Middle East & Africa Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Stimulation Systems
    • 10.1.2. Accessories
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
    • 10.2.2. Transspinal Magnetic Stimulation
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Stimulation Site
    • 10.3.1. Cervical Spine
    • 10.3.2. Thoracic Spine
    • 10.3.3. Lumbosacral Spine
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Spinal Cord Injury Rehabilitation
    • 10.4.2. Stroke & Neurological Motor Rehabilitation
    • 10.4.3. Autonomic Dysfunction Management
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Hospitals
    • 10.5.2. Specialty Clinics
    • 10.5.3. Homecare Settings
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
      • 10.6.1.1. By Product Type
    • 10.6.2. South Africa
      • 10.6.2.1. By Product Type
    • 10.6.3. Rest of Middle East & Africa
      • 10.6.3.1. By Product Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ONWARD Medical
    • 11.2.2. ANEUVO
    • 11.2.3. SpineX Inc.
    • 11.2.4. COSIMA
    • 11.2.5. University of Washington
    • 11.2.6. Kessler Foundation
    • 11.2.7. University of Louisville
    • 11.2.8. University of Miami

List of Tables

  • Table 1: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 3: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 4: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 5: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 6: Global Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 7: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 8: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 9: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 10: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 11: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 12: North America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 13: U.S. Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Canada Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 15: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 16: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 17: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 18: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 19: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 20: Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Germany Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 22: U.K. Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 23: France Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 24: Italy Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 25: Spain Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Scandinavia Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 27: Rest of Europe Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 28: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 29: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 30: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 31: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 32: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 33: Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 34: China Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 35: Japan Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 36: India Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 37: Australia Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 38: Southeast Asia Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 39: Rest of Asia Pacific Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 40: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 41: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 42: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 43: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 44: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 45: Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 46: Brazil Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 47: Mexico Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 48: Rest of Latin America Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 49: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 50: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Technology, 2021-2034
  • Table 51: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Stimulation Site, 2021-2034
  • Table 52: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 53: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 54: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 55: GCC Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 56: South Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 57: Rest of Middle East & Africa Non-invasive Spinal Cord Stimulation Market Revenue (USD million) Forecast, by Product Type, 2021-2034

List of Figures

  • Figure 1: Global Non-invasive Spinal Cord Stimulation Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025 & 2034
  • Figure 5: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025 & 2034
  • Figure 7: Global Non-invasive Spinal Cord Stimulation Market Value Share (%), by Region, 2025 & 2034
  • Figure 8: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 9: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Technology, 2025 & 2034
  • Figure 11: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025
  • Figure 12: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Stimulation Site, 2025 & 2034
  • Figure 13: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025
  • Figure 14: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Application, 2025 & 2034
  • Figure 15: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025
  • Figure 16: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), by End User, 2025 & 2034
  • Figure 17: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025
  • Figure 18: North America Non-invasive Spinal Cord Stimulation Market Value (USD million), By Country, 2025 & 2034
  • Figure 19: North America Non-invasive Spinal Cord Stimulation Market Value Share (%), By Country, 2025
  • Figure 20: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 21: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), by Technology, 2025 & 2034
  • Figure 23: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025
  • Figure 24: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), by Stimulation Site, 2025 & 2034
  • Figure 25: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025
  • Figure 26: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), by Application, 2025 & 2034
  • Figure 27: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025
  • Figure 28: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), by End User, 2025 & 2034
  • Figure 29: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025
  • Figure 30: Europe Non-invasive Spinal Cord Stimulation Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Non-invasive Spinal Cord Stimulation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), by Technology, 2025 & 2034
  • Figure 35: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025
  • Figure 36: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), by Stimulation Site, 2025 & 2034
  • Figure 37: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025
  • Figure 38: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), by End User, 2025 & 2034
  • Figure 41: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025
  • Figure 42: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Non-invasive Spinal Cord Stimulation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 45: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Technology, 2025 & 2034
  • Figure 47: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025
  • Figure 48: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Stimulation Site, 2025 & 2034
  • Figure 49: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025
  • Figure 50: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), by Application, 2025 & 2034
  • Figure 51: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), by End User, 2025 & 2034
  • Figure 53: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025
  • Figure 54: Latin America Non-invasive Spinal Cord Stimulation Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Non-invasive Spinal Cord Stimulation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), by Technology, 2025 & 2034
  • Figure 59: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), by Technology, 2025
  • Figure 60: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), by Stimulation Site, 2025 & 2034
  • Figure 61: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), by Stimulation Site, 2025
  • Figure 62: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), by End User, 2025 & 2034
  • Figure 65: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), by End User, 2025
  • Figure 66: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Non-invasive Spinal Cord Stimulation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Non-invasive Spinal Cord Stimulation Market Share (%), By Company, 2025